Colorectal, Cancer Clinical Trials in Dallas, Texas
12 recruitingDallas, Texas
Showing 1–12 of 12 trials
Recruiting
Phase 1
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
Colorectal, Cancer
EMD Serono Research & Development Institute, Inc.200 enrolled35 locationsNCT05464030
Recruiting
Phase 1Phase 2
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Breast CancerTriple-Negative Breast CancerColorectal, Cancer+26 more
PMV Pharmaceuticals, Inc300 enrolled76 locationsNCT04585750
Recruiting
Phase 1Phase 2
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Colorectal, CancerEsophageal CancerGastric Cancer+18 more
Neonc Technologies, Inc.134 enrolled6 locationsNCT06047379
Recruiting
Phase 4
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
Colorectal, Cancer
Takeda78 enrolled45 locationsNCT06562543
Recruiting
Phase 2
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Breast CancerColorectal, CancerEsophageal Cancer+9 more
Jazz Pharmaceuticals200 enrolled21 locationsNCT06695845
Recruiting
Phase 1Phase 2
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Colorectal, CancerGastric CancerPancreatic Ductal Adenocarcinoma+2 more
Blue Earth Diagnostics71 enrolled1 locationNCT07432633
Recruiting
Phase 1Phase 2
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Colorectal, CancerNon-small Cell Lung Cancer (NSCLC)Pancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc.534 enrolled53 locationsNCT06128551
Recruiting
Phase 1
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
Colorectal, CancerGastric CancerEndometrial Cancer+4 more
MOMA Therapeutics132 enrolled13 locationsNCT06974110
Recruiting
Phase 1Phase 2
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
Triple-Negative Breast CancerColorectal, CancerOvarian Cancer+6 more
Apollo Therapeutics Ltd100 enrolled9 locationsNCT06399757
Recruiting
Phase 1Phase 2
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Colorectal, CancerEsophageal CancerGastric Cancer+5 more
Merus B.V.523 enrolled45 locationsNCT03526835
Recruiting
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
Triple-Negative Breast CancerColorectal, CancerNon-small Cell Lung Cancer+1 more
Persephone Biosciences5,000 enrolled10 locationsNCT04638751
Recruiting
Phase 1
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
Triple-Negative Breast CancerColorectal, CancerOvarian Cancer+1 more
Hefei TG ImmunoPharma Co., Ltd.38 enrolled2 locationsNCT05746897